Stocktoria
CAPRICOR THERAPEUTICS, INC. CAPR
CAPRICOR THERAPEUTICS, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22.3M | $25.2M | $2.6M | $244,898 | $310,250 | $1.0M | $1.7M | $2.7M | $4.0M |
| R&D expense | $84.5M | $50.0M | $36.4M | $21.8M | $13.6M | $8.5M | $5.1M | $12.1M | $10.8M | $16.0M |
| Operating income | -$108.1M | -$42.6M | -$24.1M | -$29.7M | -$20.9M | -$13.7M | -$7.7M | -$15.3M | -$12.9M | -$17.0M |
| Interest expense | — | — | — | — | — | — | — | $0 | $398,807 | $344,665 |
| Income tax | $1,600 | $1,600 | — | — | — | — | — | — | — | — |
| Net income | -$105.0M | -$40.5M | -$22.3M | -$29.0M | -$20.0M | -$13.7M | -$7.6M | -$15.2M | $2.4M | -$18.8M |
| EPS (diluted) | $-2.26 | $-1.15 | $-0.83 | $-1.18 | $-0.87 | $-0.88 | — | $-0.52 | $0.09 | $-1.01 |
| Operating cash flow | -$69.8M | -$40.0M | -$25.6M | $4.9M | -$16.8M | -$10.1M | -$6.8M | -$13.9M | -$14.2M | -$15.8M |
| Free cash flow | -$72.7M | -$41.2M | -$26.9M | $2.9M | -$18.0M | -$10.6M | -$6.8M | -$14.2M | -$14.3M | -$16.0M |
| Cash & equivalents | $287.8M | $11.3M | $14.7M | $9.6M | $34.9M | $32.7M | $3.9M | $4.3M | $6.1M | $3.2M |
| Total assets | $355.9M | $170.5M | $58.7M | $50.1M | $41.3M | $34.6M | $11.1M | $9.2M | $16.3M | $18.7M |
| Total liabilities | $50.2M | $25.0M | $36.1M | $38.3M | $10.0M | $6.4M | $4.3M | $4.6M | $5.0M | $22.8M |
| Shareholders' equity | $305.8M | $145.5M | $22.6M | $11.8M | $31.4M | $28.2M | $6.8M | $4.6M | $11.2M | -$4.0M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -100.0% | -11.5% | +868.4% | +961.7% | -21.1% | -69.1% | -39.9% | -37.3% | -33.3% | -27.5% |
| Net income growth | — | — | — | — | — | — | — | -724.8% | — | — |
| EPS growth | — | — | — | — | — | — | — | -677.8% | — | — |
| Free cash flow growth | — | — | -1022.7% | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.